Integrated Data Repository Toolkit (IDRT)

2016 ◽  
Vol 55 (02) ◽  
pp. 125-135 ◽  
Author(s):  
B. Baum ◽  
J. Christoph ◽  
I. Engel ◽  
M. Löbe ◽  
S. Mate ◽  
...  

SummaryBackground: In recent years, research data warehouses moved increasingly into the focus of interest of medical research. Nevertheless, there are only a few center-independent infrastructure solutions available. They aim to provide a consolidated view on medical data from various sources such as clinical trials, electronic health records, epidemiological registries or longitudinal cohorts. The i2b2 framework is a well-established solution for such repositories, but it lacks support for importing and integrating clinical data and metadata.Objectives: The goal of this project was to develop a platform for easy integration and administration of data from heterogeneous sources, to provide capabilities for linking them to medical terminologies and to allow for transforming and mapping of data streams for user-specific views.Methods: A suite of three tools has been developed: the i2b2 Wizard for simplifying administration of i2b2, the IDRT Import and Mapping Tool for loading clinical data from various formats like CSV, SQL, CDISC ODM or biobanks and the IDRT i2b2 Web Client Plugin for advanced export options. The Import and Mapping Tool also includes an ontology editor for rearranging and mapping patient data and structures as well as annotating clinical data with medical terminologies, primarily those used in Germany (ICD-10-GM, OPS, ICD-O, etc.).Results: With the three tools functional, new i2b2-based research projects can be created, populated and customized to researcher’s needs in a few hours. Amalgamating data and metadata from different databases can be managed easily. With regards to data privacy a pseudonymization service can be plugged in. Using common ontologies and reference terminologies rather than project-specific ones leads to a consistent understanding of the data semantics.Conclusions: i2b2’s promise is to enable clinical researchers to devise and test new hypothesis even without a deep knowledge in statistical programing. The approach pre -sented here has been tested in a number of scenarios with millions of observations and tens of thousands of patients. Initially mostly observant, trained researchers were able to construct new analyses on their own. Early feedback indicates that timely and extensive access to their “own” data is appreciated most, but it is also lowering the barrier for other tasks, for instance checking data quality and completeness (missing data, wrong coding).

2007 ◽  
Vol 16 (01) ◽  
pp. 22-29
Author(s):  
D. W. Bates ◽  
J. S. Einbinder

SummaryTo examine five areas that we will be central to informatics research in the years to come: changing provider behavior and improving outcomes, secondary uses of clinical data, using health information technology to improve patient safety, personal health records, and clinical data exchange.Potential articles were identified through Medline and Internet searches and were selected for inclusion in this review by the authors.We review highlights from the literature in these areas over the past year, drawing attention to key points and opportunities for future work.Informatics may be a key tool for helping to improve patient care quality, safety, and efficiency. However, questions remain about how best to use existing technologies, deploy new ones, and to evaluate the effects. A great deal of research has been done on changing provider behavior, but most work to date has shown that process benefits are easier to achieve than outcomes benefits, especially for chronic diseases. Use of secondary data (data warehouses and disease registries) has enormous potential, though published research is scarce. It is now clear in most nations that one of the key tools for improving patient safety will be information technology— many more studies of different approaches are needed in this area. Finally, both personal health records and clinical data exchange appear to be potentially transformative developments, but much of the published research to date on these topics appears to be taking place in the U.S.— more research from other nations is needed.


2021 ◽  
Author(s):  
Monika Hagen ◽  
Danette Newton ◽  
Jonathan Richina ◽  
Petra Gambon Stow ◽  
Jonathan Douissard

BACKGROUND Registries are a valuable tool for data collection and observation of medical innovations in a real-world setting. Serenity LiquidTM and Serenity GenomeTM are newly launched diagnostic platforms analyzing large genetic datasets in combination with clinical data to deliver precision preventative medicine. To this point, no systematic data is available to observe the use and clinical implementations of these platforms. OBJECTIVE To create a data repository collecting data from Serenity LiquidTM, Serenity GenomeTM, and clinical parameters for analyses. METHODS Individuals receiving Serenity LiquidTM or Serenity GenomeTM are solicited to participate in this registry. In addition to the initial dataset, a clinical update is secured every six months. Data from the registry participants are pseudo-anonymized and archived in a HIPPA-compliant research database for regular analyses. RESULTS Includes but is not limited to correlations between genetic and clinical data, the impact of genetic data on the clinical course of patients, comparisons between specific cohorts (within this database and against historical cohorts) on an ongoing basis. CONCLUSIONS This is a prospective registry collecting genetic and clinical data to gather important information, provide novel insights by continuously analyzing the data in this registry.


2018 ◽  
Author(s):  
Mian Zhang ◽  
Yuhong Ji

A problem facing healthcare record systems throughout the world is how to share the medical data with more stakeholders for various purposes without sacrificing data privacy and integrity. Blockchain, operating in a state of consensus, is the underpinning technology that maintains the Bitcoin transaction ledger. Blockchain as a promising technology to manage the transactions has been gaining popularity in the domain of healthcare. Blockchain technology has the potential of securely, privately, and comprehensively manage patient health records. In this work, we discuss the latest status of blockchain technology and how it could solve the current issues in healthcare systems. We evaluate the blockchain technology from the multiple perspectives around healthcare data, including privacy, security, control, and storage. We review the current projects and researches of blockchain in the domain of healthcare records and provide the insight into the design and construction of next generations of blockchain-based healthcare systems.


Author(s):  
Mairead Bermingham ◽  
Archie Campbell ◽  
David Porteous ◽  
Angus Walls

ABSTRACT BackgroundElectronic health records provides unprecedented opportunity for their re-use in genetic epidemiological research. However, electronic health records data from clinical settings, such as dental practices may be inaccurate or of insufficient granularity to be of use in research. In this study, we wish to determine the utility of National Health Service (NHS) electronic dental treatment records in genetic epidemiological research. ObjectiveTo estimate the heritability of periodontal disease using NHS electronic dental treatment records linked to health and non-health data within the Generation Scotland: Scottish Family Health Study (GS:SFHS). ApproachWe linked 852,355 NHS Scotland electronic dental treatment records from April 2000 to July 2015 to 20,626 participants within the GS:SFHS with pedigree, genomic, sociodemographic and clinical data. We then conducted a proof-of-principle genetic epidemiological analysis using periodontal (gum) disease treatment records. The data set analysed, consisted of 160,508 dental treatment records from 13,717 study participants; 3,387 of which were periodontal treatment records (from 2,192 study participants). We adjusted for the effects of previous treatment record, interval since last treatment, age, sex, treatment year, and treatment month, Scottish index of multiple deprivation, alcohol consumption, diabetes diagnosis, and smoking status in a linear model in the statistical software ASReml. We then calculated the mean risk of periodontal disease for each study participant based on residuals extracted from the aforementioned model. Genome-complex trait analysis (GCTA; with correction for population stratification) was used to estimate the pedigree and genomic based heritability of periodontal disease. ResultsWe estimate the familial heritability of periodontal (gum) disease at 10.42% (95% confidence interval 5.97-14.88%). The genomic component did not contribute significantly to the heritability estimate. Conclusionwe have demonstrated the usefulness of electronic dental treatment records in population based genetic epidemiological research .This study has also, to the best of our knowledge provided the first population based estimates of the genetic parameters for periodontal disease; confirming its familial nature. This invaluable and unique data resource will allow the acceleration of oral health research in Scotland and the exploration of research questions that could not be considered previously.


2011 ◽  
pp. 133-145 ◽  
Author(s):  
James G. Anderson

Information technology such as electronic medical records (EMRs), electronic prescribing, and clinical decision support systems are recognized as essential tools in all developed countries. However, the U.S. lags significantly behind other countries that are members of the Organization for Economic Cooperation and Development (OECD). Significant barriers impede wide-scale adoption of these tools in the U.S., especially EMR systems. These barriers include lack of access to capital by healthcare providers, complex systems, and lack of data standards that permit exchange of clinical data, privacy concerns and legal barriers, and provider resistance. Overcoming these barriers will require subsidies and performance incentives by payers and government, certification and standardization of vendor applications that permit clinical data exchange, removal of legal barriers, and convincing evidence of the cost-effectiveness of these IT applications.


Science ◽  
2019 ◽  
Vol 363 (6426) ◽  
pp. 448-450 ◽  
Author(s):  
W. Nicholson Price ◽  
Margot E. Kaminski ◽  
Timo Minssen ◽  
Kayte Spector-Bagdady

Sign in / Sign up

Export Citation Format

Share Document